These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 11152340

  • 1. Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist.
    MacDonald TJ, Taga T, Shimada H, Tabrizi P, Zlokovic BV, Cheresh DA, Laug WE.
    Neurosurgery; 2001 Jan; 48(1):151-7. PubMed ID: 11152340
    [Abstract] [Full Text] [Related]

  • 2. alpha v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin.
    Taga T, Suzuki A, Gonzalez-Gomez I, Gilles FH, Stins M, Shimada H, Barsky L, Weinberg KI, Laug WE.
    Int J Cancer; 2002 Apr 10; 98(5):690-7. PubMed ID: 11920637
    [Abstract] [Full Text] [Related]

  • 3. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.
    Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA.
    Cell; 1994 Dec 30; 79(7):1157-64. PubMed ID: 7528107
    [Abstract] [Full Text] [Related]

  • 4. Integrin control of the transforming growth factor-β pathway in glioblastoma.
    Roth P, Silginer M, Goodman SL, Hasenbach K, Thies S, Maurer G, Schraml P, Tabatabai G, Moch H, Tritschler I, Weller M.
    Brain; 2013 Feb 30; 136(Pt 2):564-76. PubMed ID: 23378223
    [Abstract] [Full Text] [Related]

  • 5. Micro-MRI at 11.7 T of a murine brain tumor model using delayed contrast enhancement.
    Moats RA, Velan-Mullan S, Jacobs R, Gonzalez-Gomez I, Dubowitz DJ, Taga T, Khankaldyyan V, Schultz L, Fraser S, Nelson MD, Laug WE.
    Mol Imaging; 2003 Jul 30; 2(3):150-8. PubMed ID: 14649058
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC, Malkowski M, Yin Z, Tanghetti E, Yaremko B, Nechuta T, Varner J, Liu M, Smith EM, Neustadt B, Presta M, Armstrong L.
    Cancer Res; 2001 Mar 01; 61(5):2232-8. PubMed ID: 11280792
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide.
    Chen X, Park R, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Moats RA, Bading JR, Laug WE, Conti PS.
    Mol Imaging Biol; 2006 Mar 01; 8(1):9-15. PubMed ID: 16315003
    [Abstract] [Full Text] [Related]

  • 8. Effect of the angiogenesis inhibitor Cilengitide (EMD 121974) on glioblastoma growth in nude mice.
    Yamada S, Bu XY, Khankaldyyan V, Gonzales-Gomez I, McComb JG, Laug WE.
    Neurosurgery; 2006 Dec 01; 59(6):1304-12; discussion 1312. PubMed ID: 17277694
    [Abstract] [Full Text] [Related]

  • 9. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.
    Cancer Res; 2002 Dec 01; 62(23):6884-90. PubMed ID: 12460903
    [Abstract] [Full Text] [Related]

  • 10. Arsenic stimulates angiogenesis and tumorigenesis in vivo.
    Soucy NV, Ihnat MA, Kamat CD, Hess L, Post MJ, Klei LR, Clark C, Barchowsky A.
    Toxicol Sci; 2003 Dec 01; 76(2):271-9. PubMed ID: 12970581
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.
    Silginer M, Burghardt I, Gramatzki D, Bunse L, Leske H, Rushing EJ, Hao N, Platten M, Weller M, Roth P.
    Oncogene; 2016 Jun 23; 35(25):3260-71. PubMed ID: 26500056
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Response to antitumor agents of human transplantable glioma implanted into chorioallantoic membrane of chick embryo].
    Nakamura O, Sasaki T, Uchida H, Tanaka M, Endo Y, Nishikawa K, Matsutani M, Takakura K.
    No Shinkei Geka; 1988 Apr 23; 16(4):353-7. PubMed ID: 3164446
    [Abstract] [Full Text] [Related]

  • 15. Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma.
    Wachsberger PR, Burd R, Marero N, Daskalakis C, Ryan A, McCue P, Dicker AP.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):835-42. PubMed ID: 15701874
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.